ai3Bio Overview
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$48M
- Investors
-
4
ai3Bio General Information
Description
Developer of biotechnology therapeutics designed to selectively eliminate disease-causing T cells for the treatment of autoimmune diseases. The company develops LNP/mRNA and antibody-based therapeutic platforms targeting pathogenic Th17 and other inflammatory T cells, enabling patients to achieve lasting remission from inflammatory disorders without broadly suppressing their body's natural defenses.
Contact Information
Website
www.aiCorporate Office
- 99 Coolidge Avenue
- Suite 201
- Watertown, MA 02472
- United States
Corporate Office
- 99 Coolidge Avenue
- Suite 201
- Watertown, MA 02472
- United States
ai3Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 29-Sep-2026 | $48M | Completed | Pre-Clinical Trials |
ai3Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A | ||||||||
| Seed 5 | ||||||||
| Seed 4 | ||||||||
| Seed 3 | ||||||||
| Seed 2 | 54,579,076 | $0.000100 | 6% | $0.29 | $0.29 | 1x | $0.29 | 0.06% |
| Seed 1 | 4,803,835 | $0.000100 | 6% | $0.68 | $0.68 | 1x | $0.68 | 0% |
ai3Bio Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cockrell Interests | Family Office | Minority | ||
| Tanis Venture Management | Venture Capital | Minority | ||
| UPMC Enterprises | Corporate Venture Capital | Minority | ||
| Ziff Capital Partners | Family Office | Minority |
ai3Bio FAQs
-
Where is ai3Bio headquartered?
ai3Bio is headquartered in Watertown, MA.
-
What industry is ai3Bio in?
ai3Bio’s primary industry is Drug Discovery.
-
Is ai3Bio a private or public company?
ai3Bio is a Private company.
-
What is the current valuation of ai3Bio?
The current valuation of ai3Bio is .
-
What is ai3Bio’s current revenue?
The current revenue for ai3Bio is .
-
How much funding has ai3Bio raised over time?
ai3Bio has raised $48M.
-
Who are ai3Bio’s investors?
Cockrell Interests, Tanis Venture Management, UPMC Enterprises, and Ziff Capital Partners have invested in ai3Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process